Drug profile · INN
gentamicin sulfate
GENTAMICIN SULFATE
gentamicin sulfate (GENTAMICIN SULFATE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — gentamicin sulfate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 1
- Programs
- 5
- Data quality
- 0.89
Quick answer
gentamicin sulfate (GENTAMICIN SULFATE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is gentamicin sulfate?
gentamicin sulfate (GENTAMICIN SULFATE) is a bacterial 70s ribosome inhibitor. Associated with Teva Pharma GmbH. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for gentamicin sulfate?
GENTAMICIN SULFATE is a marketed brand name for gentamicin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gentamicin sulfate?
gentamicin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.